Literature DB >> 15449010

CT findings in severe thoracic sarcoidosis.

Anne-Sophie Hennebicque1, Hilario Nunes, Pierre-Yves Brillet, Hassen Moulahi, Dominique Valeyre, Michel W Brauner.   

Abstract

Severe thoracic sarcoidosis includes manifestations with significant clinical and functional impairment and a risk of mortality. Severe thoracic sarcoidosis can take on various clinical presentations and is associated with increased morbidity. The purpose of this article was to describe the CT findings in severe thoracic sarcoidosis and to explain some of their mechanisms. Subacute respiratory insufficiency is a rare and early complication due to a high profusion of pulmonary lesions. Chronic respiratory insufficiency due to pulmonary fibrosis is a frequent and late complication. Three main CT patterns are identified: bronchial distortion, honeycombing and linear opacities. CT can be helpful in diagnosing some mechanisms of central airway obstruction such as bronchial distortion due to pulmonary fibrosis or an extrinsic bronchial compression by enlarged lymph nodes. An intrinsic narrowing of the bronchial wall by endobronchial granulomatous lesions may be suggested by CT when it shows evidence of bronchial mural thickening. Pulmonary hypertension usually occurs in patients with end-stage pulmonary disease and is related to fibrotic destruction of the distal capillary bed and to the resultant chronic hypoxemia. Several other mechanisms may contribute to the development of pulmonary hypertension including extrinsic compression of major pulmonary arteries by enlarged lymph nodes and secondary pulmonary veno-occlusive disease. Aspergilloma colonization of a cavity is the main cause of hemoptysis in sarcoidosis. Other rare causes are bronchiesctasis, necrotizing bronchial aspergillosis, semi-invasive pulmonary aspergillosis, erosion of a pulmonary artery due to a necrotic sarcoidosis lesion, necrosis of parenchymal sarcoidosis lesions and specific endobronchial macroscopic lesions.

Entities:  

Mesh:

Year:  2004        PMID: 15449010     DOI: 10.1007/s00330-004-2480-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients.

Authors:  T Franquet; N L Müller; A Giménez; P Domingo; V Plaza; R Bordes
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

2.  Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings.

Authors:  N L Müller; J B Mawson; J R Mathieson; R Abboud; D N Ostrow; P Champion
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

3.  Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment.

Authors:  M Remy-Jardin; F Giraud; J Remy; L Wattinne; B Wallaert; A Duhamel
Journal:  Radiology       Date:  1994-06       Impact factor: 11.105

4.  Endobronchial mass lesion due to sarcoidosis: complete resolution with corticosteroids.

Authors:  B F Corsello; G H Lohaus; A Funahashi
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

5.  Necrotizing bronchial aspergillosis as a cause of hemoptysis in sarcoidosis.

Authors:  M Fujimura; Y Ishiura; K Kasahara; T Amemiya; S Myou; Y Hayashi; Y Watanabe; E Takazakura; A Nonomura; T Matsuda
Journal:  Am J Med Sci       Date:  1998-01       Impact factor: 2.378

6.  Sarcoidosis simulating pulmonary veno-occlusive disease.

Authors:  V Hoffstein; N Ranganathan; J B Mullen
Journal:  Am Rev Respir Dis       Date:  1986-10

7.  Chronic cor pulmonale in pulmonary sarcoidosis.

Authors:  J P Battesti; R Georges; F Basset; G Saumon
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

8.  Sarcoidosis: assessment of disease severity using HRCT.

Authors:  Marjolein Drent; Jolanda De Vries; Merinke Lenters; Rob J S Lamers; Snjezana Rothkranz-Kos; Emiel F M Wouters; Marja P van Dieijen-Visser; Johny A Verschakelen
Journal:  Eur Radiol       Date:  2003-06-17       Impact factor: 5.315

9.  Aspergillomas complicating sarcoidosis. A prospective study in 100 patients.

Authors:  C Wollschlager; F Khan
Journal:  Chest       Date:  1984-10       Impact factor: 9.410

10.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

View more
  10 in total

Review 1.  Rare causes of pulmonary hypertension: spectrum of radiological findings and review of the literature.

Authors:  Alice Rossi; Maurizio Zompatori; Patrick Tchouante Tchouanhou; Michele Amadori; Massimiliano Palazzini; Elisa Conficoni; Nazzareno Galiè; Venerino Poletti; Giampaolo Gavelli
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

2.  Chest Computed Tomography-Based Scoring of Thoracic Sarcoidosis: Inter-rater Reliability of CT Abnormalities.

Authors:  D A Van den Heuvel; P A de Jong; P Zanen; H W van Es; J P van Heesewijk; M Spee; J C Grutters
Journal:  Eur Radiol       Date:  2015-04-09       Impact factor: 5.315

3.  The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.

Authors:  Karen C Patterson; Kyle Hogarth; Aliya N Husain; Anne I Sperling; Timothy B Niewold
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

Review 4.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 5.  [Lung cavities, mycetomas and hemoptysis].

Authors:  Wolfgang Domej; Josef Hermann; Robert Krause; Martin Wehrschütz; Alfred Maier; Erich Flögel
Journal:  Wien Med Wochenschr       Date:  2007

Review 6.  Sarcoidosis.

Authors:  Hilario Nunes; Diane Bouvry; Paul Soler; Dominique Valeyre
Journal:  Orphanet J Rare Dis       Date:  2007-11-19       Impact factor: 4.123

7.  Pulmonary Sarcoidosis Presenting with Thin-walled Small Cysts.

Authors:  Hisako Kushima; Hiroshi Ishii; Jun-Ichi Kadota; Kentaro Watanabe
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

8.  Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.

Authors:  Robert P Baughman; Oksana A Shlobin; Rohit Gupta; Peter J Engel; Jeffrey I Stewart; Elyse E Lower; Franck F Rahaghi; Joyce Zeigler; Steven D Nathan
Journal:  Chest       Date:  2021-08-04       Impact factor: 9.410

9.  Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis.

Authors:  Cheryl S Pirozzi; Daniel L Mendoza; Yizhe Xu; Yue Zhang; Mary Beth Scholand; Robert P Baughman
Journal:  Int J Environ Res Public Health       Date:  2018-05-26       Impact factor: 3.390

10.  Rare case of pulmonary sarcoidosis with cystic bronchiectasis.

Authors:  Keishi Sugino; Atsuko Kurosaki; Sakae Homma; Kazuma Kishi
Journal:  BMJ Case Rep       Date:  2020-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.